CAS RN: 700-63-0
DL-2-Phenylglycinamide
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260216
1g / 5g / 25g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 700-63-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥97%
0
Out of Stock
Hong Kong
Inquiry
700-63-0 / 2-amino-2-phenylacetamide
Standard CAS: 700-63-0
Multi CAS: Yes
Basic Information
copy
CAS
700-63-0 copy
Multi CAS
Yes copy
Molecular Formula
C8H10N2O copy
Molecular Weight
150.180000 copy
Exact Mass
150.079313 copy
InChI
InChI=1S/C8H10N2O/c9-7(8(10)11)6-4-2-1-3-5-6/h1-5,7H,9H2,(H2,10,11) copy
InChIKey
KIYRSYYOVDHSPG-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.12 copy
Rotatable bonds
2 copy
H-bond acceptors
2 copy
H-bond donors
2 copy
Molar refractivity
42.56 copy
TPSA
69.11 copy
LogP / Solubility
WLOGP
0.17 copy
MLOGP
0.15 copy
XLogP3
-0.1 copy
Consensus LogP
0.07 copy
Log S (ESOL)
-1.15 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-0.92 copy
Class (Ali)
Very soluble copy
Log S (SILICOS-IT)
-1.02 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.51 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy